elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26849675-0B0E5A29-AD56-45CF-845E-6DBE4BFB130A
Q26849675-0B0E5A29-AD56-45CF-845E-6DBE4BFB130A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26849675-0B0E5A29-AD56-45CF-845E-6DBE4BFB130A
Risk definition and management strategies in retinoblastoma: current perspectives
P2860
Q26849675-0B0E5A29-AD56-45CF-845E-6DBE4BFB130A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26849675-0B0E5A29-AD56-45CF-845E-6DBE4BFB130A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a748705d55a432004bd26e00dc65d6096645c40
P2860
Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.